INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 5.50
0.00 (0.00%)
At close: Nov 3, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 591.11 million as of November 4, 2026. It is the 28,165th most valuable company in the world and the 197th biggest in Norway. Its market cap has increased by 28.06% in one year.
Market Cap
591.11M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#197 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 591.11M, an increase of 30.67%. That is a compound annual growth rate of 6.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 537.37M | 40.71% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.45B |
| Circio Holding ASA | 2.89B |
| Nordhealth AS | 1.94B |
| Thor Medical ASA | 1.75B |
| Nykode Therapeutics AS | 1.00B |
| Omda AS | 933.10M |
| Vistin Pharma ASA | 835.90M |
| Gentian Diagnostics ASA | 616.80M |